Certified by Founder Lodge
Newpath Partners
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $270,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Newpath is a private venture capital investment fund focused on disruptive treatments and technologies in the life science space. We search for innovative approaches across diverse fields inc
| Company | Date | Round | Raised |
|---|---|---|---|
Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
Orbital Therapeutics
Myeloid Therapeutics
Magnet Biomedicine
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Scorability | $11,000,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)